Sonoma Pharmaceuticals (SNOA) rises 216% on COVID-19 disinfectant approval
Sonoma Pharmaceuticals (SNOA) surged a staggering 216% after the approval of their COVID-19 disinfectant when an Australian regulator gave the green light for the wound-care-product company to